How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Rose Hip Oil (Cas 84603-93-0) Market
- By Source Type: Wild Rose Hip Oil, Cultivated Rose Hip Oil, Organic Rose Hip Oil
- By Form: Cold-Pressed Oil, Refined Oil, Fractionated Oil
- By Application: Skincare Products, Haircare Products, Pharmaceuticals, Nutraceuticals, Cosmetics
- By Distribution Channel: Online Retail, Specialty Stores, Pharmacies, Direct Sales, Supermarkets/Hypermarkets
- By Purity Grade: 100% Pure Rose Hip Oil, Blended Rose Hip Oil, Rose Hip Oil Extracts
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Wild Rose Hip Oil leads By Source Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 291 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.177 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.185 →
Full report · locked preview
Everything inside the Rose Hip Oil (Cas 84603-93-0) Market report
A complete, evidence-based study - 12 chapters and 122 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Source Type 3
Form 3
Application 5
Distribution Channel 5
Purity Grade 3
Companies profiled
Aromantic
Lebermuth Company
Botanic Innovations
Eden Botanicals
Naissance
The Herbarie
Mountain Rose Herbs
Berg + Schmidt
Aromatics International
Essential Wholesale & Labs
Plant Therapy
New Directions Aromatics
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Aromantic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Lebermuth Company
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Botanic Innovations
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Eden Botanicals
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Naissance
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →The Herbarie
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Mountain Rose Herbs
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Berg + Schmidt
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Aromatics International
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Essential Wholesale & Labs
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Plant Therapy
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →New Directions Aromatics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Florihana
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Oils of Heaven
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Sibu Beauty
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$3,704M by 2033 · 5.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Wild Rose Hip Oil66.5
- Cultivated Rose Hip Oil12.1
- Organic Rose Hip Oil21.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$790.6M → $1,277M · 6.2%
Europe$551.0M → $917.5M · 6.6%
Asia Pacific$503.1M → $694.8M · 4.1%
Latin America$311.4M → $531.7M · 6.9%
Middle East and Africa$239.6M → $330.6M · 4.1%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →5.542026
5.562027
5.572028
5.592029
5.592030
5.612031
5.622032
5.622033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Aromantic23.8
- Lebermuth Company17.1
- Botanic Innovations8.0
- Eden Botanicals6.7
- Naissance4.6
- The Herbarie11.7
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Source Type13.9%
Form21.5%
Application22.2%
Distribution Channel20.7%
Purity Grade21.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.0
- Europe24.5
- Asia Pacific18.5
- Latin America14.2
- Middle East and Africa8.8
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Aromantic | 74 | 98 | 74 | 98 | 88 | 87 | 87 |
| Lebermuth Company | 72 | 80 | 72 | 77 | 75 | 76 | 75 |
| Botanic Innovations | 85 | 87 | 86 | 66 | 67 | 82 | 79 |
| Eden Botanicals | 66 | 57 | 75 | 62 | 81 | 71 | 69 |
| Naissance | 67 | 64 | 71 | 69 | 76 | 70 | 70 |
| The Herbarie | 47 | 67 | 62 | 67 | 68 | 68 | 63 |
| Mountain Rose Herbs | 55 | 62 | 43 | 51 | 58 | 57 | 54 |
| Berg + Schmidt | 51 | 52 | 55 | 41 | 39 | 41 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Aromantic
- Lebermuth Company
- Botanic Innovations
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Aromantic | − | ◐ | ✓ | ◐ | ✓ | ✓ |
| Lebermuth Company | ◐ | ◐ | ◐ | ◐ | ◐ | ✓ |
| Botanic Innovations | ✓ | ✓ | ✓ | ◐ | ✓ | ◐ |
| Eden Botanicals | ◐ | − | ◐ | ◐ | ✓ | ◐ |
| Naissance | ◐ | ◐ | ✓ | ✓ | ◐ | ◐ |
| The Herbarie | − | − | ◐ | − | ◐ | ◐ |
| Mountain Rose Herbs | − | ◐ | ◐ | ◐ | − | ◐ |
| Berg + Schmidt | ◐ | ◐ | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Aromantic87
2Botanic Innovations79
3Lebermuth Company75
4Naissance70
5Eden Botanicals69
6The Herbarie63
7Mountain Rose Herbs54
8Berg + Schmidt47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
AromanticBotanic Innovations
Challenger3
Strong scale, closing on the leaders.
Lebermuth CompanyEden BotanicalsNaissance
Contender1
Focused players with pockets of strength.
The Herbarie
Niche2
Specialists in a single segment or region.
Mountain Rose HerbsBerg + Schmidt
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Source Type in North America, then scale across Rose Hip Oil (Cas 84603-93-0) Market — a $473M beachhead inside a $7.74B market.
Beachhead (SOM)$473Mobtainable near-term
Serviceable (SAM)$2.88Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Wild Rose Hip Oil
Best fit — highest urgency & budget in Source Type.
Economic buyer79 fit
Cultivated Rose Hip Oil
Strong fit — clear ROI and a fast path to value.
End user64 fit
Organic Rose Hip Oil
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Source Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Form & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel27%
Digital / self-serve21%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Source Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Rose Hip Oil (Cas 84603-93-0) Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified23%
Evaluation13%
Closed-won6%
$21.1KCAC
$109KLTV
5.2:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Rose Hip Oil (Cas 84603-93-0) Market is a durable-growth opportunity — $2.48B by 2033, compounding at 8.3%.
TAM · 2025$1.31Btoday
TAM · 2033$2.48Bforecast
CAGR8.3%2027–2033
Cumulative$16.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$2.48BTotal addressable market
SAM$979MServiceable available market
SOM$161MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.3% CAGR
Demand compounds through 2033, outpacing GDP across Source Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Source Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$2.48BLarge & growingTAM by 2033 at 8.3% CAGR
$979MServiceable nowreachable with today’s model
$161MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.93BBear5.4% CAGR
$2.48BBase8.3% CAGR
$3.17BBull11.0% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Form optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Rose Hip Oil (Cas 84603-93-0) Market — a $3.97B market by 2033. Plan: grow share from 9.9% to 15.6%.
Market size · 2033$3.97Btotal addressable
Market CAGR8.8%2027–2033
Target share15.6%from 9.9% today
Revenue ambition$620Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.9% | 15.6% | On track |
| Revenue | $426M | $620M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 31.5% | 42.0% | On track |
| Customer retention | 86.6% | 96.0% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Source Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Form capability
A defensible second engine — invest in Form to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Source Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Form
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $91M capacity & capability investment
- Greenlight bolt-on M&A in Form
- Authorise North America expansion plan
- Fund R&D program for Source Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAhead
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Rose Hip Oil (Cas 84603-93-0) Market conversation — a $10.7B market you can size, segment and defend in minutes.
Market size · 2033$10.7Btotal opportunity
Growth11.1%CAGR to 2033
Addressable buyers1,552+accounts in scope
Typical ROI7.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Source Type
Goal Grow share in Source Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.3×return on cost, year one
< 4 mopayback period
$62K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
AromanticLebermuth CompanyBotanic InnovationsEden BotanicalsNaissanceThe HerbarieMountain Rose HerbsBerg + Schmidt+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Rose Hip Oil (Cas 84603-93-0) Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Rose Hip Oil (Cas 84603-93-0) Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Rose Hips Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportRose Quartz Bracelet Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportRose Quartz Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportRosehip Oil for Personal Care Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportRosehip Oil for Skin Care Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportRosemary Extract Sales Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportRosemary Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportRosettes Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportRosin (CAS 8050-09-7) Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportRosin Amines Market
Market size, share, segmentation and regional forecast.
$655M market · 2025 base year
View reportRosin Maleic Acid Glycerol Ester Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportRosin Modified Resin Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.